Mr. Balkema has served as a Director of the Company since February 2016. Mr. Balkema most recently served as the President of Bayer Healthcare LLC and Worldwide Consumer Care Division, retiring in 2011. He joined Bayer in 1995 as President of the U.S. Consumer Care Division to merge 2 OTC drug businesses, and repositioned Bayer Aspirin following a 10-year decline into a growing business and assumed additional responsibilities over time, culminating in leading their worldwide OTC business. Prior to Bayer, Mr. Balkema was Vice President and General Manager responsible for American Cyanamid Co.’s Lederle Consumer Health Division, responsible for their OTC drug business. He joined American Cyanamid Co. in 1977, assuming increasing roles of responsibility over time. Mr. Balkema has served in the leadership of the key consumer products industry associations, including Chairman of the Consumer Healthcare Products Association, Chairman of the World Self Medication Industry, and a member of the leadership council for the National Association of Chain Drug Stores. He currently serves on the Board of Directors of Brady Corporation since 2010, where he is the Chair of the Management Development & Compensation Committee and is a member of the Audit Committee.